MVP — Medical Developments International Income Statement
0.000.00%
- AU$65.91m
- AU$50.06m
- AU$39.06m
- 73
- 51
- 71
- 75
Annual income statement for Medical Developments International, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | C2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 25.3 | 21.9 | 32.3 | 33.1 | 39.1 |
Cost of Revenue | |||||
Gross Profit | 19.2 | 15.2 | 22.2 | 24.4 | 29.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 40.3 | 38.2 | 59.3 | 66.4 | 40.8 |
Operating Profit | -15 | -16.3 | -27 | -33.2 | -1.76 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -15 | -15.9 | -7.49 | -32.9 | 0.168 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.6 | -12.4 | -5.61 | -41 | 0.094 |
Net Income Before Extraordinary Items | |||||
Net Income | -12.6 | -12.4 | -5.61 | -41 | 0.094 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.6 | -12.4 | -5.61 | -41 | 0.094 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.008 | -0.159 | -0.142 | -0.343 | 0.001 |
Dividends per Share |